AC Immune SA (ACIU)
3.13
+0.12
(+3.81%)
USD |
NASDAQ |
Mar 16, 16:00
3.15
+0.02
(+0.64%)
After-Hours: 20:00
AC Immune Market Cap : 314.88M for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 295.52B |
| EvoNext Holdings SA | 8.438M |
| Kuros Biosciences Ltd. | 1.228B |
| Basilea Pharmaceutica AG | 871.29M |
| Santhera Pharmaceuticals Holding AG | 263.33M |
Market Cap Related Metrics
| PS Ratio | 73.75 |
| PEG Ratio | -0.0812 |
| Price to Book Value | 5.558 |
| Price | 3.13 |
| Earnings Yield | -26.82% |
| PEGY Ratio | -0.0812 |